Polymorphism of genes SOCS5 and EGFR with bronchial asthma
- Authors: Averyanov A.B1, Chercashina I.I1, Nikulina S.Y.1, Shestovitskiy V.A1
-
Affiliations:
- Prof. V.F.Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 20, No 3 (2018)
- Pages: 45-47
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95009
- DOI: https://doi.org/10.26442/2075-1753_20.3.45-47
- ID: 95009
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
A. B Averyanov
Prof. V.F.Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federation
Email: Averyanov_a007@mail.ru
аспирант каф. внутренних болезней 660022, Russian Federation, Krasnoyarsk, ul. Partizana Zhelezniaka, d. 1
I. I Chercashina
Prof. V.F.Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federation
Email: cherkashina@list.ru
д-р мед. наук, проф. каф. внутренних болезней 660022, Russian Federation, Krasnoyarsk, ul. Partizana Zhelezniaka, d. 1
S. Yu Nikulina
Prof. V.F.Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federation
Email: nikulina@mail.ru
д-р мед. наук, проф., зав. каф. внутренних болезней №1, проректор по учебной работе 660022, Russian Federation, Krasnoyarsk, ul. Partizana Zhelezniaka, d. 1
V. A Shestovitskiy
Prof. V.F.Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federationд-р мед. наук, проф., каф. терапии 660022, Russian Federation, Krasnoyarsk, ul. Partizana Zhelezniaka, d. 1
References
- March M.E., Sleiman P.M., Hakonarson H. The genetics of asthma and allergic disorders. Discovery Medicine 2011; 56 (11): 35-45.
- Салтыкова И.В., Фрейдин М.Б., Брагина Е.Ю. и др. Ассоциация полиморфизма rs6737848 гена SOCS5 с бронхиальной астмой. вестн. рос. академии медицинских наук. 2013; 7: 53-6. doi: 10.15690/vramn.v68i7.713
- Global Initiative for Asthma. Global strategy for asthma management and prevention. 2016 [Accessed 2016]. Available on [www.ginasthma.org].
- Чучалин А.Г. Бронхиальная астма. M.: Медицина, 2003.
- Чучалин А.Г., Илькович M.M. Справочник по пульмонологии. М.: ГЭОТАР-Медиа, 2014.
- Фрейдин М.Б., Огородова Л.М., Цой А.Н., Бердникова Н.Г. Генетика бронхиальной астмы. Генетика бронхолегочных заболеваний. М.: Атмосфера, 2010; с. 78-104.
- Vercelli D. Discovering susceptibility genes for asthma and allergy. Nature Reviews Immunology 2008; 8 (3): 169-82. doi: 10.1038/nri2257
- Балаболкин И.И., Булгакова В.А. Генетические аспекты формирования эффективности и безопасности фармакотерапии и атопической бронхиальной астмы у детей. Фарматека. 2016; 14: 14-9.
- Разводовская А.В., Черкашина И.И., Никулина С.Ю. и др. Изучение ассоциации однонуклеотидного полиморфизма rsl800470 гена трансформирующего фактора роста бета 1 (TGF-P1) с риском развития бронхиальной астмы. Сиб. мед. обозрение. 2014; 2: 17-22. doi: 10.20333/25000136-2014-2-17-22.
- Черкашина И.И., Никулина С.Ю., Максимов В.Н. и др. Особенности полиморфизма гена хемокинового рецептора CCR2 у больных бронхиальной астмой и хронической обструктивной болезнью легких. Сиб. мед. обозрение. 2013; 2: 19-23.
- Li Y, Wu B, Xiong H et al. Polymorphisms of STAT-6, STAT-4 and IFN-gamma genes and the risk of asthma in Chinese population. Respir Med 2007; 101 (9): 1977-81. doi: 10.1016/j.rmed.2007.04.006
- Hsieh Y.Y, Wan L, Chang C.C. et al. STAT2*C related genotypes and allele but not TLR4 and CD40 gene polymorphisms are associated with higher susceptibility for asthma. Int J Biol Sci 2009; 5 (1): 74-81. doi: 10.7150/ijbs.5.74
- Ege M.J., Mayer M, Schwaiger K. et al. Environmental bacteria and childhood asthma. Allergy 2012; 67 (12): 1565-71. doi: 10.1111/all.12028
- Hilty M, Burke C, Pedro H et al. Disordered microbial communities in asthmatic airways. PLoS One 2010; 5 (1): е8578. DOI: 10.1371 /journal.pone.0008578
- Seki Y, Hayashi K, Matsumoto A et al. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proceedings of the National Academy of Sciences of the USA. 2002; 99 (20): 13003-8. doi: 10.1073/pnas.202477099
- O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8 (3): 275-83. doi: 10.1016/s1074-7613(00)80533-6
- Хаитов Р.М., Пинегин Б.В., Ярилин А.А. Руководство по клинической иммунологии. Диагностика заболеваний иммунной системы: Руководство для врачей. М.: ГЭОТАР-Медиа, 2009.
- Athanassakis I, Vassiliadis S. T regulatory cells: are we re-discovering T suppressors. Immunology Letters 2002; 84: 179-83. doi: 10.1016/s0165-2478(02)00182-7
- Murphy K.M, Ouyang W, Farrar J.D. et al. Signaling and transcription in T helper development. Аnnu Rev Immunol 2000; 18: 451-94. doi: 10.1146/annurev.immunol.18.1.451
- Фрейдлин И.С. Регуляторные Т-клетки: происхождение и функции. Мед. иммунология. 2005; 7 (4): 347-54.
- Ouyang W, Lohning M, Gao Z et al. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 2000; 12: 27-37. doi: 10.1016/s1074-7613(00)80156-9
- Lee H-J, Takemoto N, Kurata H et al. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J Exp Med 2000; 192: 105-15. doi: 10.1084/jem.192.1.105
- Kubo M, Ransom J, Webb D et al. T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. The EMBO J 1997; 16: 4007-20. doi: 10.1093/emboj/16.13.4007
- Huang H, Paul W.E. Impaired interleukin 4 signaling in T helper type 1 cells. J of Exp Med 1998; 187: 1305-313. doi: 10.1084/jem.187.8.1305
- Hsu S.C., Miller S.A., Wang Y, Hung M.C. Nuclear EGFR is required for cisplatin resistance and DNA repair. Am J Transl Res 2009; 1: 249-58. doi: 10.1158/0008-5472.can-10-2384
- Bai J, Guo X.G., Bai X.P. Epidermal growth factor receptor-related DNA repair and radiation-resistance regulatory mechanisms: a mini-review. Asia Pac J Cancer Prevent 2012; 13: 4879-81. doi: 10.7314/apjcp.2012.13.10.4879
- Rodemann H.P, Dittmann K, Toulany M. Radiation-induced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol 2007; 83: 781-91. doi: 10.1080/09553000701769970
- Sharma S.V, Bell D.W., Settleman J, Haber D.A. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007; 7: 169-81. doi: 10.1038/nrc2088
- Albitar L, Pickett G, Morgan M et al. EGFR isoforms and gene regulation in human endo-metrial cancer cells. Molecular Cancer 2010; 9: 166. doi: 10.1186/1476-4598-9-166
- Guillaudeau A, Durand K, Rabinovitch-Chable H et al. Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain. Int J Oncol 2012; 40: 1142-52. doi: 10.3892/ijo.2011.1287
- Arau J.A., Ribeiro R, Azevedo I et al. Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer - a review of the literature. Oncologist 2007; 12: 201-10. doi: 10.1634/theoncologist.12-2-201
- Yang P.W., Hsieh M.S., Huang Y.C. et al. Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma. PLoS One 2014; 9 (6): e100326. DOI: 10.1371 /journal.pone.0100326
- Zhang J, Zhan Z, Wu J et al. Association among polymorphisms in EGFR gene exons, lifestyle and risk of gastric cancer with gender differences in Chinese Han subjects. PLoS One 2013; 8 (3): e59254. doi: 10.1371/journal.pone.0059254
- Gerger A, El-Khoueiry A, Zhang W et al. Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res 2011; 17 (17): 5783-92. doi: 10.1158/1078-0432.CCR-11-1115
- Li C, Wei R, Jones-Hall YL et al. Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study. Sci Reports 2014; 4: 4893. doi: 10.1038/srep04893
- Huang C.M., Chen H.H., Chen D.C. et al. Rheumatoid arthritis is associated with rs17337023 polymorphism and increased serum level of the EGFR protein. PLoS One 2017; 12 (7): e0180604. DOI: 10.1371 /journal.pone.0180604
- Yoshikawa T, Kanazawa H. Integrated effect of EGFR and PAR-1 signaling crosstalk on airway hyperresponsiveness. Int J Mol Med 2012; 30 (1): 41-8. doi: 10.3892/ijmm.2012.981
- Le Cras T.D., Acciani T.H., Mushaben E.M. et al. Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. Am J Physiol Lung Cell Mol Physiolog 2011; 300 (3): 414-21. doi: 10.1152/ajplung.00346.2010
- Hilton D.J. Negative regulators of cytokine signal transduction. Cell Mol Life Sci 1999; 55: 1568-77. doi: 10.1007/s000180050396
- Naka T, Fujimoto M, Kishimoto T. Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. Trends Biochem Sci 1999; 24: 394-8. doi: 10.1016/s0968-0004(99)01454-1
- Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Аnnu Rev Immunol 2000; 18: 143-64. doi: 10.1146/annurev.immunol.18.1.143
- Feng Z.P, Chandrashekaran I.R, Low A et al. The N-terminal domains of SOCS proteins: a conserved region in the disordered N-termini of SOCS4 and 5. Proteins 2012; 80 (3): 946-57. doi: 10.1002/prot.23252
- Saltykova I.V, Ogorodova L.M, Bragina E.Y et al. Opisthorchis felineus liver fluke invasion is an environmental factor modifying genetic risk of atopic bronchial asthma. Acta Tropica 2014; 139: 53-6. doi: 10.1016/j.actatropica.2014.07.004
- Linossi E.M, Chandrashekaran I.R, Kolesnik T.B et al. Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1. PLoS One 2013; 8 (8): e70536. DOI: 10.1371 /journal.pone.0070536
- Zhuang G, Wu X, Jiang Z et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. The EMBO J 2012; 31 (17): 3513-23. doi: 10.1038/emboj.2012.183
- Yoon S, Yi Y.S, Kim S.S et al. SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues. Tumour Biol 2012; 33 (1): 215-21. doi: 10.1007/s13277-011 -0264-4
- Ozaki A, Seki Y, Fukushima A, Kubo M. The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model. J Immunol 2005; 175 (8): 5489-97. doi: 10.4049/jimmunol.175.8.5489
- Toghi M, Taheri M, Arsang-Jang S et al. SOCS gene family expression profile in the blood of multiple sclerosis patients. J Neurol Sci 2017; 375: 481-5. doi: 10.1016/j.jns.2017.02.015
- Kario E, Marmor M.D, Adamsky K et al. Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling. J Biol Chemistry 2005; 280 (8): 7038-48. doi: 10.1074/jbc.M408575200